Ticker name:RNAAtrium Therapeutics, Inc.

Country: US-Sector: Healthcare, Industry: Biotechnology

Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart. Their development-stage portfolio currently includes ATR 1072, a siRNA-based therapy targeting the PRKAG2 gene for the treatment of PRKAG2 syndrome, and ATR 1086, another siRNA therapy aimed at the PLN gene to address PLN cardiomyopathy. The company is also actively developing a wider range of pipeline candidates designed to combat various genetic and cardiac diseases. Founded in 2025, Atrium Therapeutics is based in San Diego, California.

Market Cap 139M

Last close 6.43$

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA136B537.79$
2REGNREGENERON PHARMACEUTICALS, INC.99B952.4$
3MRNAModerna, Inc.87B215.27$
4RVMDRevolution Medicines, Inc.36B166.87$
5GMABGENMAB A/S32B51.57$
6ROIVRoivant Sciences Ltd.28B38.61$
7INSMINSMED Inc27B122.88$
8UTHRUNITED THERAPEUTICS Corp25B587.88$
9INCYINCYTE CORP25B120.27$
10ALNYALNYLAM PHARMACEUTICALS, INC.21B159.73$
11ASNDAscendis Pharma A/S18B271.73$
12NBIXNEUROCRINE BIOSCIENCES INC17B165.31$
13EXELEXELIXIS, INC.16B67.1$
14JAZZJazz Pharmaceuticals plc15B239.77$
15BBIOBridgeBio Pharma, Inc.15B77.36$
16TECHBIO-TECHNE Corp11B72.79$
17BMRNBIOMARIN PHARMACEUTICAL INC11B57.99$
18HALOHALOZYME THERAPEUTICS, INC.11B96.5$
19KYMRKymera Therapeutics, Inc.11B125.85$
20MDGLMADRIGAL PHARMACEUTICALS, INC.9.8B423.96$